Researchers from the Slovak Academy of Sciences (SAV) and Comenius University (UK) developed a new antimicrobial protein, an endolysin, which could be key to treating various bacterial diseases, ...
About SER-155 SER-155 is an investigational, oral, live biotherapeutic designed to decolonize gastrointestinal (GI) pathogens, improve epithelial barrier integrity, and induce immune tolerance to ...